Cellosaurus logo
expasy logo

Cellosaurus TU-OC-1 (CVCL_L700)

[Text version]
Cell line name TU-OC-1
Synonyms TUOC1; Tottori University-Ovarian Clear cell-1
Accession CVCL_L700
Resource Identification Initiative To cite this cell line use: TU-OC-1 (RRID:CVCL_L700)
Comments Part of: MD Anderson Cell Lines Project.
Population: Japanese.
Doubling time: 38.4 +- 3.5 hours (PubMed=23430509).
Omics: Protein expression by reverse-phase protein arrays.
Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
Sequence variations
  • Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=23430509).
Disease Ovarian clear cell adenocarcinoma (NCIt: C40078)
Clear cell adenocarcinoma of the ovary (ORDO: Orphanet_398971)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 65Y
Category Cancer cell line
Web pages https://tcpaportal.org/mclp/
Publications

PubMed=23430509; DOI=10.1007/s13577-013-0062-y
Itamochi H., Kato M., Nishimura M., Oumi N., Oishi T., Shimada M., Sato S., Naniwa J., Sato S., Nonaka M., Kudoh A., Terakawa N., Kigawa J., Harada T.
Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.
Hum. Cell 26:121-127(2013)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

Cross-references
Cell line databases/resources cancercelllines; CVCL_L700
Encyclopedic resources Wikidata; Q54973329
Polymorphism and mutation databases Cosmic; 1889261
Cosmic; 2482703
Entry history
Entry creation06-May-2013
Last entry update05-Oct-2023
Version number15